glp-1 and substance use disorder drugs linked to lower addiction rates in large study of veterans | Science GLP1 receptor agonists are supported
Description
These warrant thyroid function testing including TSH, free T4, and free T3
Kelly MS, Scopelliti EM, Goodson KE, Cma L, Nguyen HX, Simon B
PubMed PMID: 38945189
While offering a much-need treatment option for patients, this class of drugs rang alarm bells for payers once the budget impact was calculated at an annual cost of nearly $18,000, based on wholesale acquisition cost combined with an adult obesity prevalence rate of 41.9% in 2017 (National Health and Nutrition Examination Survey, 2020)
Normally, doctors start you on a low dose and gradually increase it to curb gastrointestinal side effects
